 1.  Short title This Act may be cited as the  Lessening Addiction By Enhancing Labeling Opioids Act of 2021  or the  LABEL Opioids Act .
 2.  Lessening addiction by enhancing labeling of opioids  (a)  In general Section 305(c) of the Controlled Substances Act ( 21 U.S.C. 825(c) ) is amended by striking  which shall provide that the label  and all that follows through the period and inserting the following:  which shall provide thatâ€”   (1)  the label of a drug listed in schedule II, III, or IV shall, when dispensed to or for a patient, contain a clear, concise warning that it is a crime to transfer the drug to any person other than the patient; and  (2)  the label of any container or package containing an opioid or opiate listed in schedule II, III, IV, or V (other than a drug that is approved or authorized by the Food and Drug Administration for the treatment of addiction or an opioid use disorder) shall, when dispensed to or for a patient, contain a clear, concise warning that the opioids or opiates dispensed can cause dependence, addiction, and overdose.  ;  (b)  Prohibited act Section 402(a)(3) of the Controlled Substances Act ( 21 U.S.C. 842(a)(3) ) is amended after  distribute  by inserting  or dispense .  (c)  Regulations  (1)  Regulations  Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall prescribe final regulations to implement the amendments made by subsections (a) and (b), which regulations shall be effective beginning on the date that is 2 years after the date of enactment of this Act.  (2)  Interim rules  The Secretary of Health and Human Services may issue the regulations required under paragraph (1) by interim rule to the extent necessary to comply with the timing requirement in paragraph (1).  (d)  Applicability  The amendment made by subsection (b) applies beginning on the date that is 2 years after the date of enactment of this Act. 
